Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice

Neuropharmacology

Volumn 37, Issue 9, 1998, Pages 1177-1184

  Kita, Taizo ^a   Paku, Shunchoru ^a   Takahashi, Masahiro ^a   Kubo, Kaoru ^a   Wagner, George C ^b   Nakashima, Toshikatsu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Dopamine; Hyperthermia; Methamphetamine; Neurotoxicity; Strain difference

Indexed keywords

3 O METHYLDOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; BENZAMIDE; DIETHYLDITHIOCARBAMIC ACID; DOPAMINE; HOMOVANILLIC ACID; METHAMPHETAMINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; HIPPOCAMPUS; HYPERTHERMIA; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STRAIN DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIDOTES; BENZAMIDES; BODY TEMPERATURE; BRAIN; CORPUS STRIATUM; DITIOCARB; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; MALE; METHAMPHETAMINE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; RECTUM; SEROTONIN; SPECIES SPECIFICITY; TIME FACTORS;

EID: 0032428111     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00106-3     Document Type: Article

References (31)

1. Albers, D.S., Sonsalla, P.K., 1995. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 275, 1104-1114.
2. Ali, S.F., Newport, G.D., Holson, R.R., Slikker, W. Jr., Bowyer, J.F., 1994. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658, 33-38.
3. Atlas, S.A., Zweier, J.L., Nebert, D.W., 1980. Genetic differences in phenytoin pharmacokinetics. In vivo clearance and in vitro metabolism among inbred strains of mice. Dev. Pharmcol. Ther. 1, 281-304.
4. Bowyer, J.F., Tank, A.W., Newport, G.D., Slikker, W. Jr., Ali, S.F., Holson, R.R., 1992. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in the rat striatum. J. Pharmcol. Exp. Thr. 260, 817-824.
5. Boyer, C.S., Ross, D., Petersen, D.R., 1988. Sex and strain differences in the hepatotoxic response to acute cocaine administration in the mouse. J. Biochem. Toxicol. 3, 295-307.
6. Cadet, J.L., Sheng, P., Ali, S., Rothman, R., Carlson, E., Epstein, C., 1994. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62, 380-383.
7. Chance, M.R.A., 1947. Factors influencing the toxicity of sympathomimetic amines to solitary mice. J. Pharmacol. Exp. Ther. 89, 289-296.
8. Cosi, C., Chopin, P., Marien, M., 1996. Benzamide, an inhibitor of poly(ADP-ribose)polymerase, attenuates methamphetamine-induced dopamine neurotoxicity in the C57B1/6N mouse. Brain Res. 735, 343-348.
9. De Vito, M.J., Wagner, G.C., 1989. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 28, 1145-1150.
10. Fleckenstein, A.E., Wilkins, D.G., Gibb, J.W., Hanson, G.R., 1997. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J. Pharmcol. Exp. Ther. 283, 281-285.
11. Fornai, F., Bassi, L., Torracca, M., Scalori, V., Corsini, G.U., 1995. Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine in mice. Eur. J. Pharmacol. 283, 99-102.
12. Gerlach, M., Riederer, P., 1996. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J. Neural. Transm. 103, 987-1041.
13. Giovanni, A., Liang, L.P., Hastings, T.G., Zigmond, M.J., 1995. Estimating hydroxy radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64, 1819-1825.
14. Hirata, H., Ladenheim, B., Rothman, R.B., Epstein, C., Cadet, J.L., 1995. Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res. 677, 345-347.
15. Itzhak, Y., Ali, S.F., 1996. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J. Neurochem. 67, 1770-1773.
16. Kita, T., Wagner, G.C., Philbert, M.A., King, L.A., Lowndes, H.E., 1995. Effects of pargyline and pyrogallol on methamphetamine-induced dopamine depletion. Mol. Chem. Neuropathol. 24, 31-41.
17. Kondo, T., Ito, T., Sugita, Y., 1994. Bromocriptine scavengers methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum. In: Chieuh, C.C., Gilbert D.L., Colton C.A. (Eds), The neurobiology of NO· and OH·. Annals of the New York Academy of Science, The New York Academy of Sciences, New York, pp. 222-229.
18. Kuribara, H., Tadokoro, S., 1989. Reverse tolerance to ambulation-increasing effects of methamphetamine and morphine in six mouse strains. Jpn. J. Pharmacol. 49, 197-203.
19. Miller, D.B., O'Callaghan, J.P., 1996. Neurotoxicity of D-amphetamines in the C57BL/6J and CD-1 mouse. In: Ali S.F., Takahashi Y. (Eds), Cellular and Molecular Mechanisms of Drugs of abuse. Annals of the New York Academy of Science, The New York Academy of Sciences, New York, pp. 148-167.
20. O'Callaghan, J.P., Miller, D.B., 1994. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270, 741-751.
21. Schmued, L.C., Bowyer, J.F., 1997. Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain Res. 759, 135-140.
22. Schraufstatter, I.U., Hyslop, P.A., Hinshaw, D.B., Spragg, R.G., Sklar, L.A., Cochrane, C.G., 1986. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA 83, 4908-4912.
23. Seiden, L.S., Vosmer, G., 1984. Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methamphetamine. Pharmacol. Biochem. Behav. 21, 29-31.
24. Seiden, L.S., Ricuarte, G.A., 1987. Neurotoxicity of methamphetamine and related drugs. In: Melzer H.Y. (Ed.), Psychopharmacology: A Third Generation of Progress. Raven Press, New York, pp. 359-366.
25. Sonsalla, P.K., Heikkila, R.E., 1988. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 12, 345-354.
26. Sonsalla, P.K., Nicklas, W.J., Heikkila, R.E., 1988. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243, 398-400.
27. Stephans, S.E., Yamamoto, B.K., 1994. Methamphetamine-induced neurotoxicity: role for glutamate and dopamine efflux. Synapse 17, 203-209.
28. Wagner, G.C., Ricaurte, G.A., Seiden, L.S., Schuster, C.R., Miller, R.J., Westley, J., 1980. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181, 151-160.
29. Wagner, G.C., Carelli, R.M., Jarvis, M.J., 1985. Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res. Commun. Chem. Pathol. Pharmacol. 47, 221-228.
30. Woolverton, W.L., Ricuarte, G.A., Forno, L.S., Seiden, L.S., 1989. Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res. 486, 73-78.
31. Zhang, J., Dawson, V.L., Dawson, T.M., Snyder, S.H., 1994. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263, 687-689.